Topical immunotherapy: What's new

Dermatologic Clinics

Volumn 23, Issue 2, 2005, Pages 245-258

  Sauder, Daniel N ^a   Mofid, Mona Z ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; BETAMETHASONE VALERATE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; DICLOFENAC; ETANERCEPT; FLUOROURACIL; HYDROCORTISONE; IMIQUIMOD; INFLIXIMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIMECROLIMUS; RECOMBINANT ALPHA INTERFERON; RESIQUIMOD; RETINOID; TACROLIMUS;

ACTINIC KERATOSIS; ALOPECIA; ANTIBODY PRODUCTION; BASAL CELL CARCINOMA; BURN; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL TRIAL; COMPLEMENT ACTIVATION; CONDYLOMA; CRYOSURGERY; CURETTAGE; CYTOKINE PRODUCTION; DRUG ABSORPTION; DRUG APPROVAL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDICATION; DRUG INFORMATION; DRUG SAFETY; DRUG TARGETING; DRUG TOLERABILITY; ERYTHEMA; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOLOGICAL MEMORY; IMMUNOTHERAPY; INNATE IMMUNITY; MOLLUSCUM CONTAGIOSUM; NONHUMAN; PAIN; PERIORAL DERMATITIS; PRIORITY JOURNAL; PRURITUS; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SKIN ALLERGY; SKIN ATROPHY; SKIN DISEASE; TELANGIECTASIA; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; WART VIRUS;

EID: 17044384136     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2004.08.002     Document Type: Review

References (143)

1. U.R. Hengge, B. Benninghoff, T. Ruzicka, and M. Goos Topical immunomodulators-progress towards treating inflammation, infection, and cancer Lancet Infect Dis 1 3 2001 189 198
2. K.J. Smith, M. Germain, and H. Skelton Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy Dermatol Surg 27 6 2001 561 564
3. M. Grundmann-Kollmann, H.C. Korting, S. Behrens, P. Kaskel, U. Leiter, and G. Krahn Mycophenolate mofetil: a new therapeutic option in the treatment of blistering autoimmune diseases J Am Acad Dermatol 40 1999 957 960
4. B. Lemaitre, E. Nicolas, L. Michaut, J.M. Reichhart, and J.A. Hoffmann The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults Cell 20;86 6 1996 973 983
5. T. Chuang, and R.J. Ulevitch Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells Biochim Biophys Acta 1518 1-2 2001 157 161
6. K. Takeda, and S. Akira Microbial recognition by Toll-like receptors J Dermatol Sci 34 2 2004 73 82
7. Armant M.A., Fenton M.J. Toll-like receptors: a family of pattern-recognition receptors in mammals. Genome Biol 2002;3(8):reviews 3011.1-reviews 3011.6
8. A.A. Gaspari, and D.N. Sauder Immunotherapy of basal cell carcinoma: evolving approaches Dermatol Surg 29 2003 1027 1034
9. D.N. Sauder Imiquimod: modes of action Br J Dermatol 149 Suppl 66 2003 5 8
10. H. Hemmi, T. Kaisho, O. Takeuchi, S. Sato, H. Sanjo, and K. Hoshino Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway Nat Immunol 3 2 2002 196 200
11. D.N. Sauder Immunomodulatory and pharmacologic properties of imiquimod J Am Acad Dermatol 43 2000 S6 S11
12. R.L. Miller, M.A. Tomai, C.J. Harrison, and D.I. Bernstein Immunomodulation as a treatment strategy for genital herpes: review of the evidence Int Immunopharmacol 2 4 2002 443 451
13. R.P. Burns Jr, B. Ferbel, M. Tomai, R. Miller, and A.A. Gaspari The imidazoquinolines, imiquimod and R-848, induce functional, but not phenotypic, maturation of human epidermal Langerhans' cells Clin Immunol 94 1 2000 13 23
14. H. Suzuki, B. Wang, G.M. Shivji, P. Toto, P. Amerio, and M.A. Tomai Imiquimod, a topical immune response modifier, induces migration of Langerhans cells J Invest Dermatol 114 1 2000 135 141
15. W. Petrow, R. Gerdsen, M. Uerlich, O. Richter, and T. Bieber Successful topical immunotherapy of bowenoid papulosis with imiquimod Br J Dermatol 145 6 2001 1022 1023
16. R. Kirnbauer, P. Lenz, and M. Okun Human papillomavirus J.L. Bolognia J.L. Jorizzo R.P. Rapini Dermatology 2003 Mosby Philadelphia 1217
17. L.A. Koutsky, D.A. Galloway, and K.K. Holmes Epidemiology of genital human papillomavirus infection Epidemiol Rev 10 1988 122 163
18. U.R. Hengge, and M. Cusini Topical immunomodulators for the treatment of external genital warts, cutaneous warts and molluscum contagiosum Br J Dermatol 149 Suppl 66 2003 15 19
19. U.R. Hengge, S. Esser, T. Schultewolter, C. Behrendt, T. Meyer, and E. Stockfleth Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum Br J Dermatol 143 5 2000 1026 1031
20. D.J. Leffell The scientific basis of skin cancer J Am Acad Dermatol 42 2000 18 22
21. E. Stockfleth, C. Ulrich, T. Meyer, and E. Christophers Epithelial malignancies in organ transplant patients: clinical presentation and new methods of treatment Recent Results Cancer Res 160 2002 251 258
22. A.K. Gupta, E.A. Cooper, S.R. Feldman, and A.B. Fleischer Jr A survey of office visits for actinic keratosis as reported by NAMCS, 1990-1999. National Ambulatory Medical Care Survey Cutis 70S 2002 8 13
23. E.W. Jeffes, and E.H. Tang Actinic keratosis. Current treatment options Am J Clin Dermatol 1 2000 167 179
24. S.J. Salasche Epidemiology of actinic keratoses and squamous cell carcinoma J Am Acad Dermatol 42 2000 4 7
25. R.M. Hurwitz, and L.E. Monger Solar keratosis: an evolving squamous cell carcinoma. Benign or malignant? Dermatol Surg 21 2 1995 184
26. R. Marks, G. Renne, and T.S. Selwood Malignant transformation of solar keratosis to squamous cell carcinoma Lancet 1 1998 795 797
27. A.A. Beg Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses Trends Immunol 23 11 2002 509 512
28. D. Grossman, and D.J. Leffell The molecular basis of nonmelanoma skin cancer: new understanding Arch Dermatol 133 10 1997 1263 1270
29. H.T. Greenway, R.C. Cornell, D.J. Tanner, E. Peets, G.M. Bordin, and C. Nagi Treatment of basal cell carcinoma with intralesional interferon J Am Acad Dermatol 15 3 1986 437 443
30. J.K. Geisse, P. Rich, A. Pandya, K. Gross, K. Andres, and A. Ginkel Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study J Am Acad Dermatol 47 3 2002 390 398
31. W. Sterry, T. Ruzicka, E. Herrera, A. Takwale, J. Bichel, and K. Andres Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion Br J Dermatol 147 6 2002 1227 1236
32. N.K. Weisberg, and M. Varghese Therapeutic response of a brother and sister with xeroderma pigmentosum to imiquimod 5% cream Dermatol Surg 28 6 2002 518 523
33. M.K. Kagy, and R. Amonette The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient Dermatol Surg 26 2000 577 578
34. K.R. Beutner, J.K. Geisse, D. Helman, T.L. Fox, A. Ginkel, and M.L. Owens Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream J Am Acad Dermatol 41 6 1999 1002 1007
35. R. Dummer, M. Urosevic, W. Kempf, K. Hoek, J. Hafner, and G. Burg Imiquimod in basal cell carcinoma: how does it work? Br J Dermatol 149 Suppl 66 2003 57 58
36. B. Berman, T. Sullivan, T. De Araujo, and M. Nadjii Expression of Fas-receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicle Br J Dermatol 149 Suppl 66 2003 59 61
37. P.H. Krammer CD95's deadly mission in the immune system Nature 407 2000 789 795
38. M.F. Naylor, N. Crowson, R. Kuwahara, K. Teague, C. Garcia, and C. Mackinnis Treatment of lentigo maligna with topical imiquimod Br J Dermatol 149 Suppl 66 2003 66 70
39. S.E. Jacob, B. Berman, M. Nassiri, and V. Vincek Topical application of imiquimod 5% cream to keloids alters expression genes associated with apoptosis Br J Dermatol 149 Suppl 66 2003 62 65
40. S.J. Rudy Imiquimod (Aldara): modifying the immune response Dermatol Nurs 14 4 2002 268 270
41. C. Bayerl, G. Feller, and S. Goerdt Experience in treating molluscum contagiosum in children with imiquimod 5% cream Br J Dermatol 149 Suppl 66 2003 25 29
42. T. Jones Resiquimod 3M Curr Opin Investig Drugs 4 2 2003 214 218
43. M.B. Sulzberger, V.H. Witten, and C.C. Smith Hydrocortisone (compound F) free alcohol ointment JAMA 152 15 1953 1456
44. E. Bornhovd, W.H. Burgdorf, and A. Wollenberg Macrolactam immunomodulators for topical treatment of inflammatory skin diseases J Am Acad Dermatol 45 5 2001 736 743
45. A.I. Lauerma, C. Surber, and H.I. Maibach Absorption of topical tacrolimus (FK506) in vitro through human skin: comparison with cyclosporin A Skin Pharmacol 10 5-6 1997 230 234
46. J.D. Bos Non-steroidal topical immunomodulators provide skin-selective, self-limiting treatment in atopic dermatitis Eur J Dermatol 13 5 2003 455 461
47. S. Truong Utilization of topical steroids and topical immmunomodulators in the United States J Am Acad Dermatol 50 3 2004 88
48. S.L. Schreiber, and G.R. Crabtree The mechanism of action of cyclosporin A and FK506 Immunol Today 13 4 1992 136 142
49. S. Wesselborg, D.A. Fruman, J.K. Sagoo, B.E. Bierer, and S.J. Burakoff Identification of a physical interaction between calcineurin and nuclear factor of activated T cells (NFATp) J Biol Chem 271 3 1996 1274 1277
50. B. Homey, T. Assmann, H.W. Vohr, P. Ulrich, A.I. Lauerma, and T. Ruzicka Topical FK506 suppresses cytokine and costimulatory molecule expression in epidermal and local draining lymph node cells during primary skin immune responses J Immunol 160 11 1998 5331 5340
51. Clinical comparison pushes AD treatment toward potency chart Dermatol Times February 7, 2004 Available at: http://www.dermatologytimes.com
52. A. Paller, L.F. Eichenfield, D.Y. Leung, D. Stewart, and M. Appell A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients J Am Acad Dermatol 44 Suppl 1 2001 S47 S57
53. A. Meshkinpour, J. Sun, and G. Weinstein An open pilot study using tacrolimus ointment in the treatment of seborrheic dermatitis J Am Acad Dermatol 49 1 2003 145 147
54. T.J. Braza, J.B. DiCarlo, S.L. Soon, and C.O. McCall Tacrolimus 0.1% ointment for seborrhoeic dermatitis: an open-label pilot study Br J Dermatol 148 6 2003 1242 1244
55. Y.V. Saripalli, J.E. Gadzia, and D.V. Belsito Tacrolimus ointment 0.1% in the treatment of nickel-induced allergic contact dermatitis J Am Acad Dermatol 49 3 2003 477 482
56. J.T. Bamford, B.A. Elliott, and I.V. Haller Tacrolimus effect on rosacea J Am Acad Dermatol 50 1 2004 107 108
57. J. Chu, M. Bradley, and M.P. Marinkovich Topical tacrolimus is a useful adjunctive therapy for bullous pemphigoid Arch Dermatol 139 6 2003 813 815
58. M.J. Ko, and C.Y. Chu Topical tacrolimus therapy for localized bullous pemphigoid Br J Dermatol 149 5 2003 1079 1081
59. S.A. Umar, P. Bhattacharjee, and R.T. Brodell Treatment of Hailey-Hailey disease with tacrolimus ointment and clobetasol propionate foam J Drugs Dermatol 3 2 2004 200 203
60. E. Ludwig, J.P. Allam, T. Bieber, and N. Novak New treatment modalities for granuloma faciale Br J Dermatol 149 3 2003 634 637
61. T. Assmann, P. Becker-Wegerich, M. Grewe, M. Megahed, and T. Ruzicka Tacrolimus ointment for the treatment of vulvar lichen sclerosus J Am Acad Dermatol 48 6 2003 935 937
62. M. Bohm, U. Frieling, T.A. Luger, and G. Bonsmann Successful treatment of anogenital lichen sclerosus with topical tacrolimus Arch Dermatol 139 7 2003 922 924
63. C. Guttman Atopic dermatitis duo Dermatol Times February 1, 2004 Available at: http://dermatologytimes.com
64. S. Reitamo, A. Remitz, H. Kyllonen, and J. Saarikko Topical noncorticosteroid immunomodulation in the treatment of atopic dermatitis Am J Clin Dermatol 3 6 2002 381 388
65. T. Zuberbier, S.U. Chong, K. Grunow, S. Guhl, P. Welker, and M. Grassberger The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils J Allergy Clin Immunol 108 2 2001 275 280
66. B.J. Rutledge Combo useful for pediatric dermatitis Dermatol Times May 1, 2004 35 Available at: http://dermatologytimes.com
67. A.K. Gupta, and M. Chow Pimecrolimus: a review J Eur Acad Dermatol Venereol 17 5 2003 493 503
68. A. Billich, H. Aschauer, A. Aszodi, and A. Stuetz Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus Int J Pharmacol 269 1 2004 29 35
69. L.F. Eichenfield, A.W. Lucky, M. Boguniewicz, R.G. Langley, R. Cherill, and K. Marshall Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents J Am Acad Dermatol 46 4 2002 495 504
70. A. Kapp, K. Papp, A. Bingham, R. Folster-Holst, J.P. Ortonne, and P.C. Potter Flare Reduction in Eczema with Elidel (infants) multicenter investigator study group. Long-term management of atopic dermatitis in infants with topical pimecrolimus, a consteroid anti-inflammatory drug J Allergy Clin Immunol 110 2 2002 277 284
71. B.J. Rutledge Pimecrolimus cream shows better tolerability Dermatol Times May 1, 2004 Available at: http://www.dermatologytimes.com
72. C.E. Crutchfield III Pimecrolimus: a new treatment for seborrheic dermatitis Cutis 70 4 2002 207 208
73. I. Brownell, L.T. Quan, and S. Hsu Topical pimecrolimus in the treatment of seborrheic dermatitis Dermatol Online J 9 3 2003 13 Available at: http://dermatology.edlib.org/93/case_reports/seborrhea/brownell.html
74. F.A. Mayoral, C. Gonzalez, N.S. Shah, and C. Arciniegas Repigmentation of vitiligo with pimecrolimus cream: a case report Dermatology 207 3 2003 322 323
75. N. Siddaiah, Q. Erickson, G. Miller, and D.M. Elston Tacrolimus-induced tinea incognito Cutis 73 4 2004 237 238
76. S. Wetzel, and A. Wollenberg Eczema molluscatum in tacrolimus treated atopic dermatitis Eur J Dermatol 14 1 2004 73 74
77. V. Liu, and B.T. Mackool Mycophenolate in dermatology J Dermatol Treatment 14 4 2003 203 211
78. A.C. Allison, and E.M. Eugui Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF) Clin Transplant 10 1 Pt 2 1996 77 84
79. A. Mehling, S. Grabbe, M. Voskort, T. Schwarz, T.A. Luger, and S. Beissert Mycophenolate mofetil impairs the maturation and function of murine dendritic cells J Immunol 165 5 2000 2374 2381
80. K.H. Katz, J.G. Marks Jr., and K.F. Helm Pemphigus foliaceus successfully treated with mycophenolate mofetil as a steroid-sparing agent J Am Acad Dermatol 42 3 2000 514 515
81. H.C. Nousari, G.J. Anhalt, and W.L. Morison Mycophenolate in psoralen-UV-A desensitization therapy for chronic actinic dermatitis Arch Dermatol 135 9 1999 1128 1129
82. M. Grundmann-Kollmann, G. Mooser, P. Schraeder, T. Zollner, P. Kaskel, and F. Ochsendorf Treatment of chronic plaque-stage psoriasis and psoriatic arthritis with mycophenolate mofetil J Am Acad Dermatol 42 5 Pt 1 2000 835 837
83. K. Neuber, I. Schwartz, G. Itschert, and A.T. Dieck Treatment of atopic eczema with oral mycophenolate mofetil Br J Dermatol 143 2 2000 385 391
84. H.C. Nousari, W. Lynch, G.J. Anhalt, and M. Petri The effectiveness of mycophenolate mofetil in refractory pyoderma gangrenosum Arch Dermatol 134 12 1998 1509 1511
85. J. WohlrabK, J.M. Plaetzer, and W.C. Neubert Topical application of mycophenolate mofetil in plaque-type psoriasis Br J Dermatol 144 2001 1263 1264
86. W.J. Loo, and P.J. Holt Bowenoid papulosis successfully treated with imiquimod J Eur Acad Dermatol Venereol 17 3 2003 363 365
87. M. Kaspari, R. Gutzmer, P. Kiehl, P. Dumke, A. Kapp, and J.P. Brodersen Imiquimod 5% cream in the treatment of human papillomavirus-16-positive erythroplasia of Queyrat Dermatology 205 1 2002 67 69
88. T. Meyer, I. Nindl, T. Schmook, C. Ulrich, W. Sterry, and E. Stockfleth Induction of apoptosis by Toll-like receptor-7 agonist in tissue cultures Br J Dermatol 149 Suppl 66 2003 9 14
89. P.D. Yesudian, and R.A. Parslew Treatment of recalcitrant plantar warts with imiquimod J Dermatol Treatment 13 1 2002 31 33
90. S.B. Tucker, A. Ali, and B.L. Ransdell Plantar wart treatment with combination imiquimod and salicylic acid pads J Drugs Dermatol 2 2 2003 124 126
91. J.D. Sparling, S.R. Checketts, and M.S. Chapman Imiquimod for plantar and periungual warts Cutis 68 6 2001 397 399
92. G. Micali, F. Dall'Oglio, and M.R. Nasca An open label evaluation of the efficacy of imiquimod 5% cream in the treatment of recalcitrant subungual and periungual cutaneous warts J Dermatol Treatment 14 4 2003 233 236
93. U. Juschka, and M. Hartmann Topical treatment of common warts in an HIV-positive patient with imiquimod 5% cream Clin Exp Dermatol 28 Suppl 1 2003 48 50
94. D.B. Khan, and U. Jappe Successful treatment of facial plane warts with imiquimod Br J Dermatol 147 5 2002 1018
95. C. Oster-Schmidt Imiquimod: a new possibility for treatment-resistant verrucae planae Arch Dermatol 137 5 2001 666 667
96. V. Poochareon, B. Berman, and A. Villa Successful treatment of butcher's warts with imiquimod 5% cream Clin Exp Dermatol 28 Suppl 1 2003 42 44
97. R. Senatori, B. Dionisi, P. Lippa, and P. Inghirami Topical imiquimod cream in the treatment of external anogenital warts: personal experience [in Italian] Minerva Ginecol 55 6 2003 541 546
98. D. Haidopoulos, E. Diakomanolis, A. Rodolakis, G. Vlachos, A. Elsheikh, and S. Michalas Safety and efficacy of locally applied imiquimod cream 5% for the treatment of condylomata acuminata of the vulva Arch Gynecol Obstet 2003 [Epub ahead of print]
99. J.T. Cox Extensive condyloma acuminata treated with imiquimod 5% cream: a case report Clin Exp Dermatol 28 Suppl 1 2003 51 54
100. J.J. Vilata, and X. Badia Effectiveness, satisfaction and compliance with imiquimod in the treatment of external anogenital warts Int J STD AIDS 14 1 2003 11 17
101. G. Campagne, M. Roca, and A. Martinez Successful treatment of a high-grade intraepithelial neoplasia with imiquimod, with vulvar pemphigus as a side effect Eur J Obstet Gynecol Reprod Biol 109 2 2003 224 227
102. L.B. Travis, J.M. Weinberg, and B.A. Krumholz Successful treatment of vulvar intraepithelial neoplasia with topical imiquimod 5% cream in a lung transplanted patient Acta Dermatol Venereol 82 6 2002 475 476
103. E. Diakomanolis, D. Haidopoulos, and K. Stefanidis Treatment of high-grade vaginal intraepithelial neoplasia with imiquimod cream N Engl J Med 347 5 2002 374
104. O.N. Richter, W. Petrow, E. Wardelmann, C. Dorn, M. Kupka, and U. Ulrich Bowenoid papulosis of the vulva-immunotherapeutical approach with topical imiquimod Arch Gynecol Obstet 268 4 2003 333 336
105. O.N. Richter, K. Kubler, J. Schmolling, M. Kupka, J. Reinsberg, and U. Ulrich Oxytocin receptor gene expression of estrogen-stimulated human myometrium in extracorporeally perfused non-pregnant uteri Mol Hum Reprod 10 5 2004 339 346
106. J.P. Arlette Treatment of Bowen's disease and erythroplasia of Queyrat Br J Dermatol 149 Suppl 66 2003 43 49
107. L.M. Heinzerling, W. Kempf, J. Kamarashev, J. Hafner, and F.O. Nestle Treatment of verrucous carcinoma with imiquimod and CO2 laser ablation Dermatology 207 1 2003 119 122
108. A.G. Danielsen, C.S. Petersen, and J. Iversen Chronic erosive herpes simplex virus infection of the penis in a human immunodeficiency virus-positive man, treated with imiquimod and famciclovir Br J Dermatol 147 5 2002 1034 1036
109. H.B. Slade, T. Schacker, M. Conant, and C. Thoming Imiquimod and genital herpes Arch Dermatol 138 4 2002 534 535
110. B. Christensen, and U.R. Hengge Recurrent urogenital herpes simplex-successful treatment with imiquimod? Sex Transm Infect 75 2 1999 132 133
111. R.B. Skinner Jr Treatment of molluscum contagiosum with imiquimod 5% cream J Am Acad Dermatol 47 2002 S221 S224
112. M. Lebwohl, S. Dinehart, D. Whiting, P.K. Lee, N. Tawfik, and J. Jorizzo Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials J Am Acad Dermatol 50 5 2004 714 721
113. K. Chen, L.M. Yap, R. Marks, and S. Shumack Short-course therapy with imiquimod 5% cream for solar keratoses: a randomized controlled trial Australas J Dermatol 44 4 2003 250 255
114. H. Tran, K. Chen, and S. Shumack Summary of actinic keratosis studies with imiquimod 5% cream Br J Dermatol 149 Suppl 66 2003 37 39
115. K.J. Smith, M. Germain, J. Yeager, and H. Skelton Topical 5% imiquimod for the therapy of actinic cheilitis J Am Acad Dermatol 47 4 2002 497 501
116. B.M. Prinz, J. Hafner, R. Dummer, G. Burg, U. Bruswanger, and W. Kempf Treatment of Bowen's disease with imiquimod 5% cream in transplant recipients Transplantation 77 5 2004 790 791
117. K. Nouri, C. O'Connell, and M.P. Rivas Imiquimod for the treatment of Bowen's disease and invasive squamous cell carcinoma J Drugs Dermatol 2 6 2003 669 673
118. K. Chen, and S. Shumack Treatment of Bowen's disease using a cycle regimen of imiquimod 5% cream Clin Exp Dermatol 28 Suppl 1 2003 10 12
119. K. Peris, T. Micantonio, and M.C. Fargnoli Successful treatment of keratoacanthoma and actinic keratoses with imiquimod 5% cream Eur J Dermatol 13 4 2003 413 414
120. N. Bhatia Imiquimod as a possible treatment for keratoacanthoma J Drugs Dermatol 3 1 2004 71 74
121. R. Sidbury, N. Neuschler, E. Neuschler, P. Sun, X.Q. Wang, and R. Miller Topically applied imiquimod inhibits vascular tumor growth in vivo J Invest Dermatol 121 5 2003 1205 1209
122. T.P. Sullivan, T. Dearaujo, V. Vincek, and B. Berman Evaluation of superficial basal cell carcinomas after treatment with imiquimod 5% cream or vehicle for apoptosis and lymphocyte phenotyping Dermatol Surg 29 12 2003 1181 1186
123. J. Geisse, I. Caro, J. Lindholm, L. Golitz, P. Stampone, and M. Owens Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies J Am Acad Dermatol 50 5 2004 722 733
124. A. Huber, J.D. Huber, R.B. Skinner Jr, R.T. Kuwahara, R. Haque, and R.A. Amonette Topical imiquimod treatment for nodular basal cell carcinomas: an open-label series Dermatol Surg 30 3 2004 429 430
125. E. Nagore, A. Sevila, O. Sanmartin, R. Botella-Estrada, C. Requena, and C. Serra-Guillen Excellent response of basal cell carcinomas and pigmentary changes in xeroderma pigmentosum to imiquimod 5% cream Br J Dermatol 149 4 2003 858 861
126. A.M. Powell, R. Russell-Jones, and R.J. Barlow Topical imiquimod immunotherapy in the management of lentigo maligna Clin Exp Dermatol 29 1 2004 15 21
127. A.M. Powell, and R. Russell-Jones Amelanotic lentigo maligna managed with topical imiquimod as immunotherapy J Am Acad Dermatol 50 5 2004 792 796
128. C. Loquai, D. Nashan, D. Metze, U. Beiteke, K.W. Ruping, and T.A. Luger Imiquimod, pegylated interferon-alpha-2b and interleukin-2 in the treatment of cutaneous melanoma metastases [in German] Hautarzt 55 2 2004 176 181
129. C. Hesling, M. D'Incan, S. Mansard, F. Franck, A. Corbin-Duval, and C. Chevenet In vivo and in situ modulation of the expression of genes involved in metastasis and angiogenesis in a patient treated with topical imiquimod for melanoma skin metastases Br J Dermatol 150 4 2004 761 767
130. Z. Qian, N.C. Zeitoun, S. Shieh, T. Helm, and A.R. Oseroff Successful treatment of extramammary Paget's disease with imiquimod J Drugs Dermatol 2 1 2003 73 76
131. J.C. Zampogna, F.P. Flowers, W.I. Roth, and A.M. Hassenein Treatment of primary limited cutaneous extramammary Paget's disease with topical imiquimod monotherapy: two case reports J Am Acad Dermatol 47 Suppl 4 2002 S229 S235
132. L.C. Wang, A. Blanchard, D.E. Judge, A.A. Lorincz, M.M. Medenica, and S. Busbey Successful treatment of recurrent extramammary Paget's disease of the vulva with topical imiquimod 5% cream J Am Acad Dermatol 49 4 2003 769 772
133. J.H. Do, S.S. McLaughlin, and A.A. Gaspari Topical imiquimod therapy for cutaneous T-cell lymphoma Skin Med 2 5 2003 316 318
134. J. Man, and M.T. Dytoc Use of imiquimod cream 5% in the treatment of localized morphea J Cutan Med Surg 2004 [Epub ahead of print]
135. Available at: http://www.springerlink.com Accessed May, 2004
136. R. Gerdsen, J. Wenzel, M. Uerlich, T. Bieber, and W. Petrow Successful treatment of chronic discoid lupus erythematosus of the scalp with imiquimod Dermatology 205 4 2002 416 418
137. B. Berman, and A. Villa Imiquimod 5% cream for keloid management Dermatol Surg 29 10 2003 1050 1051
138. R.T. Kuwahara, and R.B. Skinner Jr Granuloma annulare resolved with topical application of imiquimod Pediatr Dermatol 19 4 2002 368 371
139. R.T. Kuwahara, M.F. Naylor, and R.B. Skinner Treatment of granuloma annulare with topical 5% imiquimod cream Pediatr Dermatol 20 1 2003 90
140. M.I. Martinez, I. Sanchez-Carpintero, P.E. North, and M.C. Mihm Jr Infantile hemangioma: clinical resolution with 5% imiquimod cream Arch Dermatol 138 7 2002 881 884
141. S. Harrison, and R. Sinclair Porokeratosis of Mibelli: successful treatment with topical 5% imiquimod cream Australas J Dermatol 44 4 2003 281 283
142. S. Agarwal, and J. Berth-Jones Porokeratosis of Mibelli: successful treatment with 5% imiquimod cream Br J Dermatol 146 2 2002 338 339
143. I. Arevalo, B. Ward, R. Miller, T.C. Meng, E. Najar, and E. Alvarez Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator Clin Infect Dis 33 11 2001 1847 1851